FGFR2 and lymphoma: While FGFR2 alterations and FGFR2 fusion proteins have been identified as drivers of intrahepatic cholangiocarcinoma [13, 38, 39], FGFR1 fusion proteins are implicated as drivers of stem cell leukemia/lymphoma.